SCHEMBL7082769

SCHEMBL7082769

C#Cc1ccsc1C(C)=O.c1cc2cc-2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORB Q92753 4/20 0.41
PKM P14618 3/20 0.39
RXFP1 Q9HBX9 2/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
BCAT2 O15382 1/20 0.35
NPSR1 Q6W5P4 2/20 0.35
PRNP P04156 1/20 0.35
PPARG P37231 1/20 0.35
NCOR2 Q9Y618 1/20 0.35
MAPK8 P45983 1/20 0.35
MAPK10 P53779 1/20 0.35
KMT2A Q03164 2/20 0.34
GAA P10253 1/20 0.34
TRPM8 Q7Z2W7 1/20 0.34
HSD17B1 P14061 1/20 0.34
HSD17B2 P37059 1/20 0.34
ALDH1A1 P00352 2/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4407689 0.86 RORB (0.45) RORBBCAT2NPSR1KMT2AMEN1
SCHEMBL3056325 0.84 KMT2A (0.45) PKMMAPTKDM4ENPSR1KMT2A
SCHEMBL22031739 0.72 GPR35 (0.46) PKMLMNANPSR1KMT2ARAB9A
SCHEMBL4404656 0.71 DHODH (0.43) PKMLMNABCAT2NPSR1KMT2A
SCHEMBL3272435 0.71 RORB (0.31) RORBKMT2AMEN1ESR1
SCHEMBL1252758 0.71 CYP2A6 (0.32) RORB
SCHEMBL506452 0.71 KDM4E (0.41) RXFP1MAPTKDM4ELMNANPSR1
SCHEMBL16863077 0.70 KMT2A (0.50) PKMRXFP1MAPTKDM4ELMNA
SCHEMBL29386504 0.68 NPC1 (0.44) RXFP1MAPTKDM4ELMNABCAT2
SCHEMBL15330090 0.67 PRNP (0.38) RXFP1MAPTKDM4ELMNABCAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030229079-A1 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof PAYNE LINDA S (US) 2003-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030229079-A1 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof CYP2S1, IMPDH1, IDO1 RORB 2131/4885PKM 2637/4885RXFP1 4846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.